Date published: 2025-10-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

2-Guanidinoethylmercaptosuccinic Acid (CAS 77482-44-1)

5.0(1)
Write a reviewAsk a question

See product citations (3)

Alternate Names:
GEMSA
Application:
2-Guanidinoethylmercaptosuccinic Acid is a potent enkephalin convertase inhibitor
CAS Number:
77482-44-1
Purity:
≥99%
Molecular Weight:
235.2
Molecular Formula:
C7H13N3O4S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

2-Guanidinoethylmercaptosuccinic Acid, also knowns as GEMSA, is a potent inhibitor of enkephalin convertase (CPE Ki = 8.8 nM), known as a carboxypeptidase B-like processing enzyme. The compound may act to be a model candidate for use in affinity chromatography of the enzyme. Studies show that 2-Guanidinoethylmercaptosuccinic Acid can influence the endogenous opioid peptide system and have a dominant affect on the central nervous system. 2-Guanidinoethylmercaptosuccinic acid is an inhibitor of carboxypeptidase N, polypeptide 1 (CPN cat).


2-Guanidinoethylmercaptosuccinic Acid (CAS 77482-44-1) References

  1. Roles of thermal instability and proteolytic cleavage in regulation of activated thrombin-activable fibrinolysis inhibitor.  |  Boffa, MB., et al. 2000. J Biol Chem. 275: 12868-78. PMID: 10777585
  2. Purification, cloning, and characterization of a profibrinolytic plasminogen-binding protein, TIP49a.  |  Hawley, SB., et al. 2001. J Biol Chem. 276: 179-86. PMID: 11027681
  3. Stabilization versus inhibition of TAFIa by competitive inhibitors in vitro.  |  Walker, JB., et al. 2003. J Biol Chem. 278: 8913-21. PMID: 12643276
  4. The role of the S1 binding site of carboxypeptidase M in substrate specificity and turn-over.  |  Deiteren, K., et al. 2007. Biochim Biophys Acta. 1774: 267-77. PMID: 17208058
  5. Molecular characterization of the carboxypeptidase B1 of Anopheles stephensi and its evaluation as a target for transmission-blocking vaccines.  |  Raz, A., et al. 2013. Infect Immun. 81: 2206-16. PMID: 23569111
  6. In vivo modulation of rat hypothalamic opioid peptide content by intracerebroventricular injection of guanidinoethylmercaptosuccinic acid (GEMSA): possible physiological role of enkephalin convertase.  |  Bommer, M., et al. 1989. Brain Res. 492: 305-13. PMID: 2665903
  7. Analgesic and convulsant effects of guanidinoethylmercaptosuccinic acid (GEMSA)--a potent enkephalin convertase inhibitor.  |  Przewlocka, B., et al. 1986. Neuropeptides. 8: 359-65. PMID: 3102992
  8. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor.  |  Bajzar, L., et al. 1995. J Biol Chem. 270: 14477-84. PMID: 7782309
  9. The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent.  |  Bajzar, L., et al. 1996. Blood. 88: 2093-100. PMID: 8822928
  10. Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme.  |  McDermott, JR. and Gibson, AM. 1997. Neurochem Res. 22: 49-56. PMID: 9021762
  11. Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.  |  Von dem Borne, PA., et al. 1997. J Clin Invest. 99: 2323-7. PMID: 9153272
  12. Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties.  |  Boffa, MB., et al. 1998. J Biol Chem. 273: 2127-35. PMID: 9442053
  13. A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor.  |  Wang, W., et al. 1998. J Biol Chem. 273: 27176-81. PMID: 9765237

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

2-Guanidinoethylmercaptosuccinic Acid, 5 mg

sc-203769
5 mg
$300.00